Actively Recruiting
Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
Led by Steno Diabetes Center Copenhagen · Updated on 2026-03-20
104
Participants Needed
2
Research Sites
93 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
CONDITIONS
Official Title
Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Type 2 diabetes (ICD-10 DE11.x)
- Age between 18 and 74 years
- Body mass index (BMI) below 35 kg/m8
- Moderately reduced kidney function with eGFR 30-59 ml/min and UACR over 30 mg/g
- Stable medication for at least 3 months
- Ability to read and understand Danish
You will not qualify if you...
- Type 1 diabetes or other types of diabetes
- Currently following a vegan diet
- Active cancer
- Having short bowel syndrome or celiac disease
- Use of sodium chloride tablets
- No access to the digital platform (required for intervention group)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Steno Diabetes Center Copenhagen,
Herlev, Captial Region of Denmark, Denmark, 2730
Actively Recruiting
2
Nordsjællands Hospital, Hillerød
Hillerød, Captial Region of Denmark, Denmark, 3400
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here